N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial. (29th January 2018)

Record Type:: Journal Article
Title:: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial. (29th January 2018)
Main Title:: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial
Authors:: Tan, W W
Hillman, D W
Salim, M
Northfelt, D W
Anderson, D M
Stella, P J
Niedringhaus, R
Bernath, A M
Gamini, S S
Palmieri, F
Perez, E A
Abstract:
Is Part Of:: Annals of oncology. Volume 29:Number 10(2018)
Journal:: Annals of oncology
Issue:: Volume 29:Number 10(2018)
Issue Display:: Volume 29, Issue 10 (2018)
Year:: 2018
Volume:: 29
Issue:: 10
Issue Sort Value:: 2018-0029-0010-0000
Page Start:: 2150
Page End:: 2150
Publication Date:: 2018-01-29
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx811 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12201.xml